These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2179967)

  • 21. Improvement and validation of a medium-term gpt delta rat model for predicting chemical carcinogenicity and underlying mode of action.
    Matsushita K; Kuroda K; Ishii Y; Takasu S; Kijima A; Kawaguchi H; Miyoshi N; Nohmi T; Ogawa K; Nishikawa A; Umemura T
    Exp Toxicol Pathol; 2014 Sep; 66(7):313-21. PubMed ID: 24929978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
    Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
    Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
    Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of initiating as well as promoting activity of chemicals by a novel cell transformation assay using v-Ha-ras-transfected BALB/c 3T3 cells (Bhas 42 cells).
    Asada S; Sasaki K; Tanaka N; Takeda K; Hayashi M; Umeda M
    Mutat Res; 2005 Dec; 588(1):7-21. PubMed ID: 16260176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Let us forget "tumour promotion" and start thinking about mechanisms of non-genotoxic carcinogenicity.
    Roe FJ
    APMIS Suppl; 1988; 2():91-9. PubMed ID: 3179036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perinatal mouse liver carcinogenesis as a sensitive carcinogenesis model and the role of the sex hormonal environment in tumor development.
    Vesselinovitch SD
    Prog Clin Biol Res; 1990; 331():53-68. PubMed ID: 2179965
    [No Abstract]   [Full Text] [Related]  

  • 29. Stochastic description of initiation and promotion in experimental carcinogenesis.
    Luebeck EG; Moolgavkar SH
    Ann Ist Super Sanita; 1991; 27(4):575-80. PubMed ID: 1840318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and epigenetic promotion of murine hepatocarcinogenesis.
    Drinkwater NR; Hanigan MH; Kemp CJ
    Prog Clin Biol Res; 1990; 331():163-76. PubMed ID: 2156269
    [No Abstract]   [Full Text] [Related]  

  • 31. Integrating pathway-based transcriptomic data into quantitative chemical risk assessment: a five chemical case study.
    Thomas RS; Clewell HJ; Allen BC; Yang L; Healy E; Andersen ME
    Mutat Res; 2012 Aug; 746(2):135-43. PubMed ID: 22305970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging issues in mouse liver carcinogenesis.
    Ward JM; Shibata MA; Devor DE
    Toxicol Pathol; 1996; 24(1):129-37. PubMed ID: 8839290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic effects of liver tumor promoters and implications for health effects.
    Williams GM
    Environ Health Perspect; 1983 Apr; 50():177-83. PubMed ID: 6873012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cytochromes P-450 in mouse liver tumor production.
    Parke DV; Ioannides C
    Prog Clin Biol Res; 1990; 331():215-30. PubMed ID: 2179958
    [No Abstract]   [Full Text] [Related]  

  • 35. Global DNA methylation screening of liver in piperonyl butoxide-treated mice in a two-stage hepatocarcinogenesis model.
    Yafune A; Kawai M; Itahashi M; Kimura M; Nakane F; Mitsumori K; Shibutani M
    Toxicol Lett; 2013 Oct; 222(3):295-302. PubMed ID: 23968726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative aspects of chemical carcinogenesis and tumor promotion in liver.
    Kunz HW; Tennekes HA; Port RE; Schwartz M; Lorke D; Schaude G
    Environ Health Perspect; 1983 Apr; 50():113-22. PubMed ID: 6223810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiation-promotion model for assessment of carcinogenicity: medium-term liver bioassay in rats for rapid detection of carcinogenic agents.
    Imaida K; Fukushima S
    J Toxicol Sci; 1996 Dec; 21(5):483-7. PubMed ID: 9035059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse liver tumor data: assessment of carcinogenic activity.
    Pereira MA
    Toxicol Ind Health; 1985 Dec; 1(4):311-33. PubMed ID: 3843510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inter-laboratory comparison of turkey in ovo carcinogenicity assessment (IOCA) of hepatocarcinogens.
    Enzmann H; Brunnemann K; Iatropoulos M; Shpyleva S; Lukyanova N; Todor I; Moore M; Spicher K; Chekhun V; Tsuda H; Williams G
    Exp Toxicol Pathol; 2013 Sep; 65(6):729-35. PubMed ID: 23121990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay.
    Dass SB; Bucci TJ; Heflich RH; Casciano DA
    Cancer Lett; 1999 Aug; 143(1):81-5. PubMed ID: 10465341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.